Steroidal and adamantane aminoacridine derivatives were prepared and tested
as both botulinum neurotoxin (BoNT) inhibitors and antimalarials.
Steroid-bound acridines provided good potency against both the BoNT/A and
BoNT/B light chains (LCs). The observed inhibition of the BoNT/B LC by ca.
50% is the highest attained inhibitory activity against this serotype by
acridine-based compounds to date. With respect to antimalarial activity,
adamantane acridines were the most potent derivatives (IC50 = 6-9 nM, SI >
326), indicating that an adamantyl group is a better carries than a steroidal
motif for this indication.
制备了类固醇和金刚烷氨基吖啶衍生物,并将其作为肉毒杆菌神经毒素(BoNT)抑制剂和抗疟药物进行了测试。
作为肉毒杆菌神经毒素(BoNT)抑制剂和抗疟药物进行了测试。
类固醇结合的吖啶对 BoNT/A 和
BoNT/B轻链(LCs)都有很好的抑制作用。所观察到的对 BoNT/B LC 的抑制率约为 50%,是所达到的最高抑制率。
50%,这是迄今为止吖啶类化合物对该血清型达到的最高抑制活性。
吖啶类化合物对该血清型的最高抑制活性。在抗疟活性方面
金刚烷吖啶是最有效的衍生物(IC50 = 6-9 nM,SI >;
326),这表明金刚烷基比甾族
基团。